Does Morbid Obesity (BMI ≥40 kg/m2) Impact Operative Time, Blood Loss, Length of Stay, or Complications Following Anatomic Total Shoulder Arthroplasty?

Document Type : RESEARCH PAPER

Authors

1 1Montefiore Medical Center - Department of Orthopedic Surgery, Bronx, New York, USA

2 2Albert Einstein College of Medicine - Department of Epidemiology & Population Health, Bronx, New York, USA

Abstract

Objectives: There have been conflicting reports regarding the effects of obesity on both surgical time and blood loss following anatomic shoulder arthroplasty. Varying categories of obesity has made comparison amongst existing studies difficult. Methods: A retrospective review of consecutive anatomic shoulder arthroplasty cases (aTSA) was undertaken. Demographic data, including age, gender, body mass index (BMI), age-adjusted Charleson Comorbidity Index (ACCI), operative time, hospital length of stay (LOS), and both POD#1 and discharge visual analogue score (VAS) was collected. Intra-operative total blood volume loss (ITBVL) and need for transfusion was calculated. BMI was categorized as non-obese (<30 kg/m2), obese (30-40 kg/m2) and morbidly obese (≥40 kg/m2). Unadjusted associations of BMI with operative time, ITBVL and LOS were examined using Spearman correlation coefficients. Regression analysis was used to identify factors associated with hospital LOS. Results: There were 130 aTSA cases performed, including 45 short stem and 85 stemless implants, of which 23 (17.7%) were morbidly obese, 60 (46.2%) were obese and 47 (36.1%) were non-obese. Median operative time for the morbidly obese cohort was 119.5 minutes (IQR 93.0, 142.0) versus 116.5 minutes (IQR 99.5, 134.5) for the obese cohort versus 125.0 minutes (IQR, 99.0, 146.0) for the non-obese cohort. (P=0.61) The median ITBVL for the morbidly obese cohort was 235.8 ml (IQR 144.3, 329.7) versus 220.1 ml (IQR 147.7, 262.7) for the obese cohort versus 216.3 ml (IQR 139.7, 315.5) for the non-obese cohort. (P=0.72). BMI ≥40kg/m2 (IRR 1.32, P=0.038), age (IRR 1.01, P=0.026), and female gender (IRR 1.54, P<0.001) were predictive of increased LOS. There was no difference with regards to in-hospital medical complications (P=0.13), surgical complications (P=1.0), need for re-operation (P=0.66) and 30-day return to the ER (P=0.06). Conclusion: Morbid obesity was not associated with increased surgical time, ITBVL and perioperative medical or surgical complications following aTSA, though it was predictive of increased hospital LOS. Level of evidence: III

Keywords

Main Subjects

References

1. Wagner ER, Farley KX, Higgins I, Wilson JM, Daly CA,
Gottschalk MB. The incidence of shoulder arthroplasty: rise
and future projections compared with hip and knee
arthroplasty. J Shoulder Elbow Surg. 2020; 29(12):2601-
2609. doi: 10.1016/j.jse.2020.03.049.
2. Dillon MT, Chan PH, Inacio MCS, Singh A, Yian EH, Navarro
RA. Yearly trends in elective shoulder arthroplasty, 2005-
2013. Arthritis Care Res (Hoboken). 2017; 69(10):1574-
1581. doi: 10.1002/acr.23167.
3. Wang YC, McPherson K, Marsh T, Gortmaker SL, Brown M.
Health and economic burden of the projected obesity trends
in the USA and the UK. Lancet .2011;378(9793):815-
825. doi: 10.1016/S0140-6736(11)60814-3.
4. Wang KY, Quan T, Best MJ, Gu A, McFarland EG, Srikumaran
U. BMI and male gender are associated with increased
operative time during total shoulder arthroplasty: an analysis
of 16,568 patients. Seminars in Arthroplasty: JSES. 2021;
31(1):346-352. doi: 10.1053/j.sart.2021.02.007.
5. Chalmers PN, Gupta AK, Rahman Z, Bruce B, Romeo AA,
Nicholson GP. Predictors of early complications of total
shoulder arthroplasty. J Arthroplasty. 2014; 29(4):856-860.
doi: 10.1016/j.arth.2013.07.002.
6. Li X, Williams PN, Nguyen JT, Craig EV, Warren RF, Gulotta LV.
Functional outcomes after total shoulder arthroplasty in
obese patients. J Bone Joint Surg Am. 2013; 95(21):e160. doi:
10.2106/JBJS.L.01145.
7. Mahmoud S, Dong Y, Loloi J, Gruson KI. Are perioperative
complications and clinical outcomes following reverse
shoulder arthroplasty adversely affected by obesity? A
systematic review. Seminars in Arthroplasty: JSES. 2021;
31(1):147-158. doi:10.1053/j.sart.2020.11.006.
8. Kashanchi KI, Nazemi AK, Komatsu DE, Wang ED. Impact of
operative time on short-term adverse events following total
shoulder arthroplasty. Seminars in Arthroplasty: JSES.
2020:30(3):227-236. doi: 10.1053/j.sart.2020.07.007.
9. Wilson JM, Holzgrefe RE, Staley CA, Karas S, Gottschalk MB,
Wagner ER. The effect of operative time on early
postoperative complications in total shoulder arthroplasty:
An analysis of the ACS-NSQIP database. Shoulder Elbow.
2021; 13(1):79-88. doi: 10.1177/1758573219876573.
10. Malcherczyk D, Abdelmoula A, Heyse TJ, Peterlein CD, Greene
B, El-Zayat BF. Bleeding in primary shoulder arthroplasty.
Arch Orthop Trauma Surg. 2018; 138(3):317-323. doi:
10.1007/s00402-017-2851-3.
11. Pappou I, Virani NA, Clark R, Cottrell BJ, Frankle MA.
Outcomes and costs of reverse shoulder arthroplasty in the
morbidly obese: a case control study. J Bone Joint Surg Am.
2014; 96:1169-1176. doi: 10.2106/JBJS.M.00735.
12. Wiater JM, Carpenter S, Koueiter DM, Marcantonio D, Wiater
BP. Influence of body mass index on clinical outcomes in
reverse total shoulder arthroplasty. J Surg Orthop Adv. 2017;
26(3):134–142. doi: 10.3113/JSOA.2017.0134.
13. Dong Y, Loloi J, Mahmoud S, Charubhumi V, Tabeayo E,
Gruson KI. The association of elevated body mass index (BMI)
with complications and outcomes following anatomic total
shoulder arthroplasty: a systematic review. Seminars in
Arthroplasty: JSES. 2022; 32(1):184-194. doi:
10.1053/j.sart.2021.05.021.
14. Charlson M, Szatrowski TP, Peterson J, Gold J. Validation of a
combined comorbidity index. J Clin Epidemiol. 1994;
47(11):1245-1251.
15. Anastasio AT, Okafor C, Garrigues GE, Klifto CS, Lassiter T,
Anakwenze O. Stemmed versus stemless total shoulder
arthroplasty: a comparison of operative times. Seminars in
Arthroplasty: JSES. 2021; 31(4):831-835. doi:
10.1053/j.sart.2021.05.013.
16. Nadler SB, Hidalgo JH, Bloch T. Prediction of blood volume in
normal human adults. Surgery. 1962; 51(2):224-232. PMID:
21936146.
17. Sehat KR, Evans RL, Newman JH. Hidden blood loss following
hip and knee arthroplasty. Correct management of blood loss
should take hidden loss into account. J Bone Joint Surg Br.
2004; 86(4):561-565.
18. Millar NL, Deakin AH, Millar LL, Kinnimonth AW, Picard F.
Blood loss following total knee replacement in the morbidly
obese: Effects of computer navigation. Knee. 2011;
18(2):108-112. doi: 10.1016/j.knee.2010.03.002.
19. Gross JB. Estimating allowable blood loss: corrected for
dilution. Anesthesiology. 1983; 58(3):277-80. doi:
10.1097/00000542-198303000-00016.
20. Wiater JM, Levy JC, Wright SA, et al. Prospective, blinded,
randomized controlled trial of stemless versus stemmed
humeral components in anatomic total shoulder arthroplasty:
results at short-term follow-up. J Bone Joint Surg Am. 2020;
102(22):1974-1984. doi: 10.2106/JBJS.19.01478.
21. Menendez ME, Baker DK, Fryberger CT, Ponce BA. Predictors
of extended length of stay after elective shoulder
arthroplasty. J Shoulder Elbow Surg. 2015; 24:1527-1533.
doi: 10.1016/j.jse.2015.02.014.
22. Griffin JW, Novicoff WM, Browne JA, Brockmeier SF. Morbid
obesity in total shoulder arthroplasty: risk, outcomes, and
cost analysis. J Shoulder Elbow Surg. 2014; 23(10):1444-8.
doi: 10.1016/j.jse.2013.12.027.
23. Bixby EC, Boddapati V, Anderson MJJ, Mueller JD, Jobin CM,
Levine WN. Trends in total shoulder arthroplasty from 2005
to 2018: lower complications rates and shorter lengths of
stay despite patients with more comorbidities. JSES Int. 2020;
4(3):657-661. doi: 10.1016/j.jseint.2020.04.024.
24. King JJ, Patrick MR, Struk AM, et al. Perioperative factors
affecting the length of hospitalization after shoulder
arthroplasty. J Am Acad Orthop Surg Glob Res Rev. 2017;
1(6):e026. doi: 10.5435/JAAOSGlobal-D-17-00026.
25. Dunn JC, Lanzi J, Kusnezov N, Bader J, Waterman BR, Belmont
PJ Jr. Predictors of length of stay after elective total shoulder
arthroplasty in the United States. J Shoulder Elbow Surg.
2015; 24(5):754-759. doi: 10.1016/j.jse.2014.11.042.
26. Hung NJ, Wong SE. Gender influences on shoulder
arthroplasty. Curr Rev Musculoskelet Med. 2022; 15(1):21-
26. doi: 10.1007/s12178-021-09737-0.
27. Sethi PM, Mandava NK, Liddy N, Denard PJ, Haidamous G,
Reimers CD. Narcotic requirements after shoulder
arthroplasty are low using a multimodal approach to pain. JSES Int. 2021; 5(4):722-728. doi:
10.1016/j.jseint.2021.02.005.
28. Werner BC, Burrus MT, Browne JA, Brockmeier SF.
Superobesity (body mass index >50 kg/m2) and
complications after total shoulder arthroplasty: an
incremental effect of increasing body mass index. J Shoulder
Elbow Surg. 2015; 24(12):1868-1875.
doi:10.1016/j.jse.2015.05.046.
29. Singh A, Yian EH, Dillon MT, Takayanagi M, Burke MF,
Navarro RA. The effect of surgeon and hospital volume on
shoulder arthroplasty perioperative quality metrics. J
Shoulder Elbow Surg. 2014; 23(8):1187-1194. doi:
10.1016/j.jse.2013.11.017. 
The Archives of Bone and Joint Surgery
Volume 11, Issue 6
June 2023
Pages 389-397

Files

History

  • Receive Date: 08 February 2023
  • Revise Date: 31 May 2023
  • Accept Date: 13 April 2023

Share

How to cite

Statistics